No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Dasatinib
-
Drug Tolerance
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Piperazines / therapeutic use
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyrimidines / therapeutic use
-
Thiazoles / therapeutic use
-
Time Factors
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Thiazoles
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases
-
nilotinib
-
Dasatinib